4295 articles
Researchers at the Auckland Bioengineering institute (ABI) have received more than $4 million in Ministry of Business, Innovation and Employment (MBIE) funding to investigate how ‘digital people’ could be used to monitor people’s health and support the management of their conditions. As part of the
Marchon Eyewear has launched Eyes on Tomorrow, a global, long-term action plan to reduce the company’s impact on the planet, including the use of more sustainable materials. The manufacturer said it
Younger Optics polarised lenses are now available for high-prescription patients with the launch of NuPolar in 1.74 high index material. Prior to this release, high-prescription patients were left
Results from the first randomised clinical trial of low-concentration atropine for myopia control in Australian children confirmed 0.01% atropine eyedrops are safe, well-tolerated and show a promising
Debuting at Silmo, tech company Ampere has launched its new electrochromic smart sunglasses, Dusk. Unlike traditional photochromic lenses, Dusk’s lenses allow the wearer to electronically adjust the
The UK’s General Optical Council’s (GOC’s) 2022 public perception survey found a record 34% of respondents hypothetically waking with an eye problem would visit an optometrist first vs 35% who would see their GP. This compares with just 19% of respondents saying they would see an optometrist first,
Some sportspeople’s eyewear is so distinctive it’s transcended mere functionality to become their trademark.
A Swiss-Irish study of keratoconus patients’ views on virtual consultations during Covid-19 found the majority preferred phonecalls to video chats and were in favour of the service continuing post-lockdown, to avoid outpatient visits.
When examining preterm infants with retinopathy of prematurity (ROP), Turkish researchers recorded better pain, heart rate and oxygen saturation levels in those who were played white noise and classical music.
iCare’s new Eidon Ultra-Widefield Module expands the retinal imaging field of view to 200˚, maximising detection of peripheral retinal pathologies.
Chicago-based health tech company Visibly’s digital acuity product (VDAP) has been approved by the US Food and Drug Administration (FDA) to become the first at-home digital vision testing platform in the US.
Japanese lens manufacturer Tokai Optical has launched its No Reflection Coating (NRC), in response to the post-pandemic reliance on screen use.